Home
TimeZone
   
Currency
   
Language
  HOME   STOCK MARKETS PORTFOLIO WATCHLIST ALERTS INDICES CONVERTER IR SERVICES MORE


Back
Corporate Information
  		• Company Presentation
  		• Business Segments
  		• Strategy & Goals
  		• President’s Message
  		• Year in Brief
  		• Management
  		• Subsidiaries
  		• Acquisitions & Divestments
  		• Addresses
    News & Reports
  		• Reports
  		• Presentations
  		• Press releases
    Financial Information
  		• Financial Summary
  		• Income Statement
  		• Balance Sheet
  		• Cash Flow
  		• Illustrations
    Shareholder Information
  		• Shareholders
  		• Shares & Dividends
  		• Annual General Meeting
  		• Financial Calendar
     
    Share Tools
  		• Share Graph
  		• Java Share Graph
  		• Investment calculator
  		• Share price look-up
       

    Kyowa Kirin Co., Ltd.

    http://www.kyowa-kirin.com     		Kyowa Kirin Co., Ltd.
    1-9-2, Otemachi, Chiyoda-ku
    100-0004 Tokyo
    JAPAN
    Tel: ‎81-3-5205-7200
    Fax: ‎81-3-5205-7129

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer
    Latest press releases  


    (2024-07-01) Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day

    (2024-06-28) Kyowa Kirin Announces Application for Additional Formulation of “LUMICEF® Subcutaneous Injection 210 mg Pen” in Japan

    (2024-06-10) Kyowa Kirin Announces Establishing New Biologics Manufacturing Plant in North Carolina, in the United States

    (2024-05-17) Kyowa Kirin Announces Approval for Partial Change of Approved Indication of G-Lasta® for the Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Blood Stem Cell Transplantation in Japan

    (2024-05-14) CTCL Global Care Collaborative Pioneers Consensus for Improving Diagnosis and Care in Cutaneous T-Cell Lymphoma (CTCL)

    (2024-05-07) Announcement of Consolidated Financial Results Fiscal 2024 First Quarter

    (2024-03-19) Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.

    (2024-03-11) Kyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024

    (2024-02-19) Kyowa Kirin Announces Launch of PHOZEVEL® Tablets for Improvement of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis in Japan

    (2024-02-07) Announcement of Consolidated Financial Results Fiscal 2023

    (2024-02-07) Notice regarding Acquisition of Own Shares and Cancellation of Treasury Shares

    (2024-02-07) BridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in Japan

    (2024-01-25) Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc (overview of the acquisition)

    (2024-01-24 00:00:01) Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases

    (2024-01-24) Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc

    (2024-01-05) Boehringer Ingelheim licenses a new compound as part of its commitment to people living with fibro-inflammatory diseases from Kyowa Kirin
       2024      2023      2022      2021      2020      2019      2018      2017      2016      2015      2014      2013      2012      2011      2010      2009      2008      2007      2006      2005      2004  
    		 
     
       Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024